IMG20260622101809.jpg

Interpret this table in simplified way

Table 15-4: Evaluating Acid-Base Status in Respiratory Acidosis

The table uses a Ratio = ΔH⁺ / ΔPco₂ (change in hydrogen ions divided by change in CO₂) to figure out what type of acid-base disorder is present.

Here's the simplified breakdown:

The Ratio and What It Means

Ratio	What's Happening	Diagnosis
< 0.3	H⁺ rise is much less than expected for the CO₂ rise	Chronic respiratory acidosis + Metabolic alkalosis (the body is over-compensating)
= 0.3	H⁺ rise matches what chronic CO₂ retention would cause	Pure Chronic Respiratory Acidosis
0.3 - 0.8	H⁺ rise is between chronic and acute expected values	Chronic respiratory acidosis + Acute respiratory acidosis (mixed) - check pH
= 0.8	H⁺ rise matches what acute CO₂ retention would cause	Pure Acute Respiratory Acidosis
> 0.8	H⁺ rise is more than even acute respiratory acidosis explains	Acute or Chronic Respiratory Acidosis + Metabolic Acidosis

The Core Concept in Simple Terms

When CO₂ rises (respiratory acidosis), H⁺ also rises - but by how much tells you the story:
- Chronic respiratory acidosis: kidneys compensate over days, so H⁺ rises only a little per unit CO₂ (ratio ~0.3)
- Acute respiratory acidosis: no kidney compensation yet, so H⁺ rises more per unit CO₂ (ratio ~0.8)
- If H⁺ rises even more than 0.8 → something extra is adding acid = metabolic acidosis on top
- If H⁺ rises less than 0.3 → something is neutralizing acid = metabolic alkalosis on top

Explain how to calculate ΔH⁺ and ΔPco₂ from lab values

How to Calculate ΔH⁺ and ΔPco₂ from ABG Values

Both values come from an Arterial Blood Gas (ABG) report.

Step 1: Get Your Lab Values

From the ABG, you need:

pH (to convert to H⁺)
PaCO₂ (directly given in mmHg)

Normal reference values:

Parameter	Normal Value
pH	7.40
H⁺	40 nmol/L
PaCO₂	40 mmHg

Step 2: Convert pH → H⁺ Concentration

pH is a logarithmic scale, so you can't subtract it directly. You must convert to H⁺ first.

The Easy Clinical Formula (the "80 minus" rule):

H⁺ (nmol/L) ≈ 80 − (last two digits of pH)

pH	Calculation	H⁺
7.40	80 - 40	= 40 nmol/L
7.30	80 - 30	= 50 nmol/L
7.20	80 - 20	= 60 nmol/L
7.50	80 - 50	= 30 nmol/L

This formula is accurate between pH 7.20 - 7.55. Outside this range, use the exact formula below.

Exact Formula (if needed):

H⁺ = 10^(9 − pH) nmol/L

Example: pH 7.30 → H⁺ = 10^(9−7.30) = 10^1.70 = 50 nmol/L

Step 3: Calculate ΔH⁺ and ΔPco₂

Once you have H⁺, both deltas are simple subtractions from normal:

ΔH⁺ = Patient's H⁺ − 40

ΔPco₂ = Patient's PaCO₂ − 40

Worked Example

ABG result: pH = 7.24, PaCO₂ = 60 mmHg

Step 1 - Convert pH to H⁺:

H⁺ = 80 − 24 = 56 nmol/L

Step 2 - Calculate deltas:

ΔH⁺ = 56 − 40 = 16
ΔPco₂ = 60 − 40 = 20

Step 3 - Calculate ratio:

Ratio = 16 ÷ 20 = 0.8

Interpretation: Ratio = 0.8 → Pure Acute Respiratory Acidosis ✓

Quick Summary

1. Read pH and PaCO₂ from ABG
2. H⁺ = 80 − (last 2 digits of pH)
3. ΔH⁺ = H⁺ − 40
4. ΔPco₂ = PaCO₂ − 40
5. Ratio = ΔH⁺ ÷ ΔPco₂ → look up in table

The whole calculation takes about 30 seconds once you memorize the 80-minus rule.

Different sodium bicarbonate preparation and its infusion dose

Reading File

Finding Sources

Searching the Web

sodium bicarbonate preparations IV infusion dose concentrations clinical

Reading File

Here is a complete breakdown of all sodium bicarbonate preparations and their dosing:

Sodium Bicarbonate (NaHCO₃) - Preparations & Dosing

Part 1: Available Preparations

A. IV Injection (Bolus) Vials/Ampules

Concentration	Strength	Volume	Content	Tonicity
8.4%	1 mEq/mL	50 mL	50 mEq per ampule	Hypertonic (2000 mOsm/L)
7.5%	0.9 mEq/mL	50 mL	44.6 mEq per ampule	Hypertonic
4.2%	0.5 mEq/mL	100 mL	50 mEq per vial	Less hypertonic

8.4% is the most commonly used in emergencies - each 50 mL ampule = 1 mEq/mL, easy to dose.

B. IV Infusion (Drip) Bags

Preparation	Volume	NaHCO₃ content	Carrier fluid
1.26%	500 mL	75 mEq	Isotonic (near-physiologic)
50 mEq in 1L	1000 mL	50 mEq	D5W, 0.45% NS, or sterile water
75 mEq in 1L	1000 mL	75 mEq	D5W or 0.45% NS
100 mEq in 1L	1000 mL	100 mEq	D5W or 0.45% NS
150 mEq in 1L	1000 mL	150 mEq	D5W or sterile water

The 1.26% (isotonic) bag is safest for large-volume infusions - least risk of hypernatremia.

C. Oral Tablets

Form	Strength
NaHCO₃ tablets	325 mg or 650 mg (= 7.7 mEq per 650 mg tablet)
KHCO₃ tablets	25-50 mEq
KHCO₃-citric acid	20-40 mEq

Part 2: Dosing by Clinical Situation

1. Metabolic Acidosis (General)

Formula:

Dose (mEq) = 0.3 × Weight (kg) × Base Deficit

Give half the calculated dose first, then recheck ABG
Non-urgent: 2-5 mEq/kg IV over 4-8 hours
Never correct fully in one go - risk of overshoot alkalosis

2. Cardiac Arrest

Initial bolus: 1 mEq/kg IV push (= 1 mL/kg of 8.4%)
Repeat: 0.5 mEq/kg every 10 minutes
Guided by ABG

3. Wide QRS / Sodium Channel Blockade (e.g., TCA overdose, beta-blocker overdose)

Bolus: 2-3 mEq/kg rapid IV over 1-2 minutes
- 70 kg patient = 140-210 mEq = 3-4 ampules of 8.4%
Goal: Narrow QRS to < 100-120 ms
Maintenance infusion: 3 ampules NaHCO₃ + 1L D5W, run at twice maintenance rate
Target serum pH: 7.50-7.55

4. Hyperkalemia (Subacute)

Use isotonic (1.26%) infusion - NOT hypertonic push
Effect on K⁺ takes 4-6 hours (not useful acutely on its own)
Hypertonic bolus does NOT lower K⁺ acutely and risks hypernatremia

5. Urinary Alkalinization (e.g., salicylate toxicity, rhabdomyolysis)

Add 150 mEq NaHCO₃ to 850 mL D5W (= 1L bag)
Infuse to maintain urine pH > 7.5 and serum pH 7.50-7.55
Monitor urine pH hourly

Part 3: Key Practical Points

Point	Detail
Central line preferred for 8.4%	Hypertonic - can cause tissue necrosis if extravasated
Peripheral use	Dilute 8.4% → use 1.26% or dilute further
Monitor:	ABG, serum Na⁺, K⁺, ionized Ca²⁺, urine pH
Caution:	Lowers ionized Ca²⁺ - do not mix with calcium solutions
Ventilation	Increase rate during infusion - NaHCO₃ generates CO₂
Overshoot risk	Never fully correct acidosis in one session

Sources: StatPearls (NCBI), Tintinalli's Emergency Medicine, Brenner & Rector's The Kidney, FDA prescribing information

Difference between ABG and VBG

Reading File

Searching the Web

ABG vs VBG difference clinical correlation pH PCO2 PO2 accuracy

Finding Sources

Reading File

Here is a complete, simplified comparison:

ABG vs VBG - Complete Comparison

Part 1: Basic Differences

Feature	ABG	VBG
Blood source	Artery (usually radial)	Vein (peripheral or central)
Pain level	More painful	Less painful
Difficulty	Technically harder	Easier
Needle-stick risk	Higher (arterial pressure)	Lower
Complications	Arterial spasm, hematoma, nerve injury, thrombosis	Minimal
Allen's test needed?	Yes (before radial puncture)	No

Part 2: How the Values Compare

Parameter	ABG (Normal)	VBG (Normal)	Difference	Reliable on VBG?
pH	7.35-7.45	7.31-7.41	VBG ~0.03-0.05 lower	✅ Yes
PCO₂	35-45 mmHg	41-51 mmHg	VBG ~4-6 mmHg higher	✅ Yes (screening)
HCO₃	22-26 mEq/L	22-26 mEq/L	Essentially same	✅ Yes
Base Excess	-2 to +2	Similar	Minimal difference	✅ Yes
PO₂	80-100 mmHg	30-50 mmHg	Very different	❌ No - use SpO₂
Lactate	<2 mmol/L	Similar	Minimal difference	✅ Yes

The key rule: VBG tells you about acid-base status reliably. It tells you nothing about oxygenation - use pulse oximetry (SpO₂) for that instead.

Part 3: The Conversion Formula

If you have a VBG and need to estimate ABG values:

Estimated ABG pH  = VBG pH + 0.05
Estimated ABG PCO₂ = VBG PCO₂ − 5 mmHg

This adjustment improves diagnostic accuracy from ~45% to ~74% (BUMC study, n=187 ICU patients).

Part 4: When to Use Each

✅ VBG is sufficient for:

Metabolic acidosis monitoring (DKA, renal failure)
Screening for hypercarbia (if VBG PCO₂ normal → arterial PCO₂ almost certainly normal)
COPD exacerbation (acid-base assessment)
Electrolyte monitoring (Na⁺, K⁺, Cl⁻, iCa²⁺)
Lactate measurement
Serial monitoring (reduces repeated arterial stabs)

❌ ABG is required when:

Oxygenation status is the primary concern (PaO₂ needed)
Respiratory failure assessment (exact PaCO₂ matters)
VBG PCO₂ is elevated (> 45 mmHg) - need the exact arterial value
Major trauma
Titrating mechanical ventilation
VBG shows abnormal result and exact arterial values are needed to guide management

Part 5: Quick Memory Aid

VBG = ACID-BASE ✅ + OXYGENATION ❌
ABG = ACID-BASE ✅ + OXYGENATION ✅

If VBG is normal → ABG is almost certainly normal
If VBG is abnormal → may need ABG to confirm and quantify

Sources: Harriet Lane Handbook (23rd ed.), Rosen's Emergency Medicine, emDocs clinical review, BUMC prospective study (n=187), Springer International Journal of Emergency Medicine

Give me full note on atrial fibrillation pathophysiology, etiology, diagnosis and management according to latest guideline for emergency physician.

Finding Sources

Searching PubMed

"atrial fibrillation"[MeSH Terms] AND "guideline"[pt]

Searching the Web

atrial fibrillation 2023 2024 ACC AHA ESC guidelines emergency management

Reading File

Finding Sources

Reading Web Page

https://amu.hr/article/current-management-of-atrial-fibrilla…

Reading File

Finding Sources

Reading File

This is a full emergency physician-oriented AF note covering everything from pathophysiology to the latest 2023 ACC/AHA and 2024 ESC guidelines. A few highlights to remember at the bedside:

WPW + AF is a trap - the wide irregular rhythm above 200 bpm needs procainamide or DC cardioversion, not AV nodal blockers
The 48-hour rule governs cardioversion safety without prior anticoagulation
ESC 2024 now recommends starting DOACs in the ED - don't defer to outpatient
80%+ of AF patients can be safely discharged from the ED after adequate rate/rhythm control
The new AF-CARE framework shifts focus toward managing underlying comorbidities (weight, OSA, hypertension, alcohol) as equal pillars alongside anticoagulation and rate/rhythm control

Pulmonary TB latest WHO update

Reading File

Searching the Web

WHO tuberculosis guidelines 2024 2025 latest update treatment

Searching PubMed

"tuberculosis"[MeSH Terms] AND "WHO" AND "guideline"[pt]

Finding Sources

Reading Web Page

https://www.who.int/news/item/08-10-2025-who-releases-new-gu…

Searching the Web

WHO consolidated guidelines tuberculosis module 4 2025 DS-TB DR-TB treatment update summary

Reading File

Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC12248249

Reading File

Searching the Web

WHO 2025 Module 4 tuberculosis 4-month regimen isoniazid rifapentine moxifloxacin pyrazinamide DS-TB update

Finding Sources

Reading File

Now I have comprehensive information from textbooks, WHO guidelines, and the latest 2025 updates. Let me compile the full note.

Pulmonary Tuberculosis - Full Clinical Note with Latest WHO 2025 Updates

Guidelines referenced:

WHO Consolidated Guidelines Module 4 (April 2025) - DS-TB & DR-TB
WHO Module 6 (October 2025) - TB & Comorbidities (Undernutrition)
ATS/CDC/ERS/IDSA 2025 Clinical Practice Guideline (AJRCCM, January 2025)
WHO Global TB Report 2024

1. EPIDEMIOLOGY & BURDEN

TB remains the leading infectious disease killer globally (second only to COVID-19 in recent years)
10.8 million new TB cases reported in 2023 (WHO Global TB Report 2024)
~10% of all TB cases are drug-resistant (MDR/RR-TB)
High-burden countries: India, Indonesia, China, Philippines, Pakistan, Nigeria, Bangladesh, South Africa
Undernutrition is the single largest modifiable risk factor (new WHO 2025 focus)

2. ETIOLOGY & MICROBIOLOGY

Causative agent: Mycobacterium tuberculosis (aerobic, slow-growing, acid-fast bacillus)
Transmission: airborne - droplet nuclei (1-5 µm) from infectious pulmonary/laryngeal TB
Infectiousness depends on: cavitary disease, AFB smear positivity, cough frequency, inadequate ventilation
Only ~10% of infected immunocompetent individuals develop active disease over a lifetime (90% maintain latent infection)

Risk Factors for Progression from Latent to Active TB

Category	Examples
Immunosuppression	HIV (highest risk - 5-10% per year), TNF-α inhibitors, organ transplant, steroids
Malnutrition	BMI < 18.5 - major independent risk factor (new WHO emphasis 2025)
Diabetes mellitus	3x increased risk
Silicosis	Occupational exposure
CKD / dialysis	Uremia-induced immune suppression
Alcohol use disorder	Social + immune factors
Recent TB infection	<2 years from exposure
Extremes of age	Infants, elderly
Tobacco smoking	Independent risk factor

3. PATHOPHYSIOLOGY

Primary Infection

Bacilli inhaled → deposited in alveoli → engulfed by alveolar macrophages
Initially uncontrolled replication → spread to hilar lymph nodes (forming Ghon complex)
Immune response (2-8 weeks): T-cell mediated → granuloma formation
Granuloma = organized collection of activated macrophages, epithelioid cells, Langhans giant cells, lymphocytes
Central caseous necrosis occurs in granuloma - this is the hallmark of TB
In most: granuloma contains infection → latent TB infection (LTBI)

Reactivation (Post-Primary TB)

Latent bacilli survive inside granulomas for years/decades
Disruption of immune control → bacilli reactivate → progressive disease
Characteristic location: apical and posterior segments of upper lobes (high O₂ tension)
Cavity formation: caseous material liquefies → drains into bronchus → cavity + airborne transmission

Key Immunology Concepts

TST (Mantoux) and IGRA measure T-cell sensitization to TB antigens - positive = prior exposure
Cavity = most infectious (highest bacillary load + direct bronchial communication)
HIV coinfection: CD4 <200 → atypical presentation, no cavity, lower lobe involvement, smear-negative but culture-positive

4. CLINICAL PRESENTATION

Pulmonary TB (most common form)

Constitutional symptoms (all are subacute/chronic):

Persistent cough >2-3 weeks (productive or dry)
Fever (low-grade, afternoon)
Night sweats
Weight loss / anorexia
Fatigue
Hemoptysis (advanced/cavitary disease)
Note: up to 25% of culture-confirmed TB do not report cough

Physical Examination:

Often non-specific
Post-tussive rales in upper zones
Amphoric (hollow) breath sounds = cavity
Advanced: signs of consolidation, pleural effusion

Special Presentations

Scenario	Features
HIV coinfection (CD4 <200)	Lower lobe, no cavity, smear-negative, miliary pattern, normal CXR possible
Miliary TB	Hematogenous dissemination, 1-2 mm granulomas in lungs/liver/bone marrow, fundoscopic choroidal tubercles
Primary progressive	Middle/lower lobe consolidation, hilar adenopathy
Elderly	Atypical symptoms, lower lobe involvement, confused with other diagnoses
TB pleuritis	Exudative effusion, pleuritic chest pain, 3-6 months post-infection
IRIS (TB-immune reconstitution)	Paradoxical worsening after starting ART in HIV patients

5. DIAGNOSIS

Step 1: Suspect TB - Who to Test

Evaluate any patient with:

Cough >2 weeks + fever/sweats/weight loss
Hemoptysis
Abnormal CXR (upper lobe infiltrate, cavity, fibrosis)
Known HIV + any respiratory symptoms
Contact with confirmed TB case
Migrant from high-burden country

Step 2: Chest Radiography

Finding	Significance
Apical/posterior upper lobe infiltrate	Classic reactivation TB
Cavitation	Active, highly infectious
Tree-in-bud opacities	Endobronchial spread
Miliary pattern (1-2 mm nodules)	Hematogenous dissemination
Ghon complex / Ranke complex	Healed primary infection
Hilar adenopathy	Primary disease
Lower lobe + no cavity	HIV-related or primary
Normal CXR	Does NOT exclude TB in HIV patients

CT chest is more sensitive than plain CXR, especially in HIV or subtle disease.

Step 3: Microbiological Diagnosis

Test	Specimen	Sensitivity	Notes
Sputum AFB smear (ZN stain)	3 sputum samples (early morning)	45-80%	Rapid, cheap; positive = infectious; negative doesn't exclude
Sputum culture (gold standard)	Sputum/BAL	80-90%	Takes 2-8 weeks (liquid media 2-3 wks; solid 6-8 wks); confirms diagnosis & DST
Xpert MTB/RIF (GeneXpert)	Sputum/BAL/tissue	88% (smear+ve), 68% (smear-ve)	WHO first-line rapid test - 2 hours; also detects rifampicin resistance
Xpert MTB/RIF Ultra	Any	Slightly more sensitive than standard	Better for paucibacillary/extrapulmonary
TB-LAMP	Sputum	Similar to smear	Point-of-care; less widely available
Line probe assay (LPA)	Culture/sputum	-	Detects INH & RIF resistance (Hain GenoType)
Whole genome sequencing	Culture	Reference	Comprehensive DST; not yet routine

Step 4: Immunological Tests

Test	Method	Interpretation
Tuberculin Skin Test (TST/Mantoux)	5 TU PPD ID → read induration at 48-72h	≥5 mm (HIV/immunocompromised); ≥10 mm (high-risk); ≥15 mm (low-risk)
IGRA (QuantiFERON-TB Gold Plus / T-SPOT.TB)	Blood test; measures IFN-γ to ESAT-6/CFP-10	Preferred over TST in BCG-vaccinated individuals

TST/IGRA = positive means prior exposure / LTBI - DOES NOT diagnose active TB. Active TB requires microbiological confirmation.

Diagnostic Algorithm (WHO-recommended)

Symptoms of TB (cough >2wks, fever, weight loss, night sweats)
        ↓
Chest X-ray
        ↓
Xpert MTB/RIF (first-line WHO diagnostic tool)
    ├─ MTB detected, RIF resistant → MDR-TB workup → LPA/DST
    ├─ MTB detected, RIF sensitive → DS-TB treatment
    └─ MTB not detected → sputum culture + clinical evaluation
                          ├─ Culture positive → TB treatment
                          └─ Culture negative + clinical improvement on treatment → culture-negative TB

6. TREATMENT - LATEST WHO & ATS/CDC 2025 UPDATES

A. Drug-Susceptible TB (DS-TB)

Standard 6-Month Regimen (remains an alternative option - WHO 2022/2025)

2HRZE / 4HR

Phase	Duration	Drugs	Abbreviation
Intensive	2 months	Isoniazid (H) + Rifampicin (R) + Pyrazinamide (Z) + Ethambutol (E)	2HRZE
Continuation	4 months	Isoniazid (H) + Rifampicin (R)	4HR

🆕 NEW 4-Month Regimen (WHO 2022 / ATS/CDC/ERS/IDSA 2025 - Conditionally Recommended)

2HPZM / 2HPM (rifapentine-moxifloxacin regimen)

Phase	Duration	Drugs
Intensive	2 months	Isoniazid (H) + Rifapentine (P) + Pyrazinamide (Z) + Moxifloxacin (M)
Continuation	2 months	Isoniazid (H) + Rifapentine (P) + Moxifloxacin (M)

Key evidence: The TBTC Study 31 / ACTG A5349 trial showed this 4-month regimen is non-inferior to the 6-month standard (disease-free survival at 12 months, similar adverse events 18.8% vs 19.3%)

Eligibility (≥12 years old):

Drug-susceptible pulmonary TB confirmed
NOT for: confirmed/suspected MDR-TB, HIV on efavirenz-based ART (drug interaction with rifapentine), pregnancy (insufficient data), extrapulmonary TB (evidence limited)

Dosing (by weight - all taken daily with food):

Drug	40-55 kg	56-75 kg	76-90 kg
Isoniazid	300 mg	300 mg	300 mg
Rifapentine	900 mg	1200 mg	1500 mg
Moxifloxacin	400 mg	400 mg	400 mg
Pyrazinamide (intensive phase only)	1000 mg	1500 mg	2000 mg

Always give pyridoxine (B6) 25-50 mg/day with isoniazid to prevent peripheral neuropathy.

🆕 4-Month Regimen for Children (Non-Severe TB, 3 months - 16 years)

2HRZE / 2HR (instead of the standard 2HRZE/4HR)

WHO now recommends the shorter 4-month regimen for children with non-severe TB (no suspicion of MDR/RR-TB)
Non-severe = peripheral lymphadenopathy, uncomplicated pulmonary disease without cavitation

B. Drug-Resistant TB (DR-TB)

Definitions

Term	Definition
MDR-TB	Resistant to isoniazid AND rifampicin
RR-TB	Rifampicin-resistant (treated same as MDR-TB)
Pre-XDR-TB	MDR/RR-TB + resistant to any fluoroquinolone
XDR-TB	MDR/RR-TB + resistant to fluoroquinolone + bedaquiline OR linezolid

🆕 BPaLM Regimen - NOW Preferred for MDR/RR-TB (WHO 2022 onwards, reinforced 2025)

6 months - BPaLM

Drug	Dose
B - Bedaquiline	400 mg OD x 2 weeks → 200 mg 3x/week x 22 weeks
Pa - Pretomanid	200 mg OD
L - Linezolid	600 mg OD (may reduce to 300 mg for toxicity)
M - Moxifloxacin	400 mg OD

If fluoroquinolone-resistant: use BPaL (without moxifloxacin) - same duration

Evidence: ZeNix and TB-PRACTECAL trials demonstrated BPaLM superior to the older 9-20 month injectable-based regimens with fewer adverse events and better treatment success rates.

WHO strongly recommends: Injectable agents (amikacin, kanamycin, capreomycin) are no longer preferred in MDR-TB - they are relegated to salvage regimens only.

Grouping of DR-TB Drugs (WHO Priority)

Group	Drugs	Role
Group A (always include if possible)	Levofloxacin OR Moxifloxacin, Bedaquiline, Linezolid	Core agents
Group B (add to complete regimen)	Clofazimine, Cycloserine/Terizidone	Add-ons
Group C (when Groups A&B insufficient)	Ethambutol, Delamanid, Pyrazinamide, Imipenem-cilastatin, Amikacin, Ethionamide, PAS	Last resort

C. Latent TB Infection (LTBI) - Preventive Therapy

Regimen	Duration	Notes
1HP (Isoniazid + Rifapentine weekly)	1 month (12 doses)	Preferred - shortest, highest completion
3HP (Isoniazid + Rifapentine weekly)	3 months (12 doses)	WHO preferred option
3HR (Isoniazid + Rifampicin daily)	3 months	Alternative
6H (Isoniazid daily)	6 months	Alternative; 9H also acceptable

7. WHO 2025 NEW UPDATES - SUMMARY

Module 4 Update (April 15, 2025)

4-month DS-TB regimen (2HPZM/2HPM) now formally included alongside the 6-month standard
Updated evidence for BPaLM as preferred MDR-TB regimen with refined dosing guidance
New guidance on treatment monitoring - culture conversion at 2 months remains key milestone
Strengthened recommendations for DST before treatment for all patients

Module 6 Update (October 7, 2025) - TB & Undernutrition

Nutritional assessment and counselling mandatory for ALL people with TB and household contacts
Nutritional interventions recommended for all TB patients with undernutrition (regardless of age, drug resistance, pregnancy, or severity)
Food assistance to household contacts in food-insecure settings to prevent TB (supported by RATIONS trial evidence)
Operational handbook released to support country-level implementation

8. MONITORING & FOLLOW-UP

Timepoint	Action
Baseline	Sputum AFB x3, culture, LFTs, CBC, creatinine, uric acid, visual acuity (if ethambutol)
2 months (end of intensive phase)	Repeat sputum culture - culture conversion is KEY prognostic marker
Monthly	Clinical assessment, symptom review, adherence check
End of treatment	Sputum smear + culture; CXR
Adverse effects monitoring	LFTs monthly (isoniazid/rifampicin hepatotoxicity); vision (ethambutol); hearing (aminoglycosides); QTc (bedaquiline, fluoroquinolones, clofazimine)

Drug-induced Hepatotoxicity (DILI) - Threshold for stopping

Stop hepatotoxic anti-TB drugs if: ALT >3x ULN with symptoms OR ALT >5x ULN without symptoms

9. INFECTION CONTROL

Airborne precautions: N95 respirator for healthcare workers (not surgical mask)
Negative pressure isolation rooms for hospitalized patients
Patient education: cover cough, natural ventilation
Continue isolation until: 3 consecutive negative sputum smears (after starting treatment)
TB is notifiable in virtually all countries

10. TB SPECIAL POPULATIONS

Population	Key Considerations
HIV + TB	Start TB treatment FIRST → add ART within 2-8 weeks (2 weeks if CD4 <50); use rifabutin instead of rifampicin with PIs; beware IRIS
Pregnancy	2HRZE/4HR standard regimen (rifampicin + pyrazinamide generally safe); avoid aminoglycosides (ototoxicity); pyridoxine essential
Children	4-month regimen for non-severe TB now recommended; weight-based dosing
Diabetes	Monitor glycaemia closely; rifampicin reduces OHG levels
CKD/Dialysis	Avoid ethambutol (accumulates); adjust pyrazinamide; rifampicin dose unchanged
Liver disease	Avoid pyrazinamide if severe; monitor LFTs closely

11. END TB STRATEGY TARGETS (2030)

90% reduction in TB deaths (vs 2015)
80% reduction in TB incidence rate
No TB-affected families facing catastrophic costs
Key 2027 milestone: license at least one new TB vaccine

Stroke recent update 2026

Finding Sources

Searching PubMed

"ischemic stroke"[MeSH Terms] AND "guideline"[pt]

Searching the Web

stroke guidelines 2025 2026 AHA ASA update ischemic stroke treatment thrombolysis thrombectomy

Reading Web Page

https://www.tctmd.com/news/ahaasa-release-new-comprehensive-…

Reading Article

PMID: 41582814

Finding Sources

Reading File

Searching the Web

2026 AHA ASA stroke guideline blood pressure management thrombectomy window extended pediatric dysphagia secondary prevention

Reading File

Reading Web Page

https://recapem.com/update-on-management-of-acute-ischemic-s…

This is the most current stroke note available, built directly from the brand-new AHA/ASA 2026 guideline (published January 26, 2026 - just 5 months ago). Here are the most important takeaways from the update:

The 5 Biggest 2026 Changes to Remember

Tenecteplase = Alteplase (Class 1) - Single bolus injection makes it much faster and easier to use. Many centers are already switching.
"Disabling vs Non-disabling" replaces NIHSS as the IVT trigger - A patient with NIHSS 2 but dominant-hand weakness that prevents their job SHOULD get IVT. A patient with NIHSS 4 but no functional impact should NOT get IVT (give DAPT instead).
Extended IVT window to 4.5-9 hours with CTP or DWI-FLAIR mismatch on imaging - important for rural areas and wake-up strokes.
EVT for large cores (ASPECTS 3-5) is now Class 1 - previously was controversial. More patients now qualify for thrombectomy even with larger infarcts on arrival.
Don't aggressively lower BP after reperfusion - targeting <140 mmHg post-reperfusion was found to harm outcomes. Permissive hypertension up to 180/105 is acceptable.

Different triage system for emergency physician

Finding Sources

Searching the Web

emergency department triage systems comparison ESI Manchester ATS CTAS START MCI 2024 2025

Finding Sources

Searching the Web

START triage SALT triage mass casualty incident MCI system categories 2025

Reading File

I now have comprehensive content. Here is the complete triage reference note:

Triage Systems for the Emergency Physician - Complete Reference

Triage derives from the French "trier" (to sort). The goal differs fundamentally between routine ED triage (identify the sickest individual) and disaster/MCI triage (do the most good for the most people).

PART 1: ED (ROUTINE) TRIAGE SYSTEMS

Five major 5-level systems are used worldwide. 5-level systems are superior to 3-level systems in both validity and reliability.

1. Emergency Severity Index (ESI) 🇺🇸

Used in: United States (most widely used), many international EDs Basis: Acuity + anticipated resource utilization Levels: 5

Level	Category	Color	Criteria	Target Time to Physician
1	Resuscitation	Red	Requires immediate life-saving intervention (intubation, defibrillation, CPR)	Immediate
2	Emergent	Orange	High-risk situation; lethargic/disoriented; severe pain/distress; dangerous vital signs	<15 min
3	Urgent	Yellow	Stable vitals but needs multiple resources (labs + imaging + IV)	<30 min
4	Less Urgent	Green	Needs one resource only (one lab OR one X-ray)	<60 min
5	Non-Urgent	Blue	Needs no resources - history + exam only	<120 min

ESI Decision Algorithm:

Step 1: Does the patient need IMMEDIATE life-saving intervention? → Level 1
Step 2: Is this a HIGH-RISK situation / confused / severe distress? → Level 2
Step 3: How many RESOURCES will this patient need?
         ≥2 resources → Level 3 (also check vital signs - abnormals bump to Level 2)
         1 resource → Level 4
         0 resources → Level 5

Vital sign thresholds that bump Level 3 → Level 2:

HR >100 or <50 | RR >20 | SpO₂ <92% | Temperature >38.5°C | Altered mentation

Pros: Simple, resource-based, widely validated, used for all ages (with pediatric modification) Cons: "Resources" subjective; poor inter-rater reliability across countries

2. Manchester Triage System (MTS) 🇬🇧

Used in: UK, Europe, Netherlands, Brazil Basis: Presenting complaint → flowchart → discriminators Levels: 5

Level	Category	Color	Target Time
1	Immediate	Red	Immediate (0 min)
2	Very Urgent	Orange	10 minutes
3	Urgent	Yellow	60 minutes
4	Standard	Green	120 minutes
5	Non-Urgent	Blue	240 minutes

How it works:

Select the presenting complaint flowchart (52 flowcharts e.g., chest pain, headache, breathing difficulty)
Work through discriminators in priority order (e.g., airway compromise → shock → extreme pain)
Assign level based on the first positive discriminator encountered

Key discriminators: Life threat, airway compromise, haemodynamic abnormality, level of consciousness, temperature, pain score

Pros: Structured, symptom-specific, systematic flowcharts, widely used in Europe Cons: Slower (~3-5 min per patient); less sensitive in elderly with atypical presentations; limited sensitivity for frail patients (2025 PLOS ONE study)

3. Canadian Triage and Acuity Scale (CTAS) 🇨🇦

Used in: Canada, some Asian and Middle Eastern countries Basis: Chief complaint + modifiers + vital signs Levels: 5

Level	Category	Color	Target Time to Physician	Reassessment
1	Resuscitation	Blue/Red	Immediate	Continuous
2	Emergent	Red/Orange	15 minutes	Every 15 min
3	Urgent	Yellow	30 minutes	Every 30 min
4	Less Urgent	Green	60 minutes	Every 60 min
5	Non-Urgent	White	120 minutes	Every 120 min

Unique features:

Only system with mandatory reassessment intervals at each level
Uses modifiers: first-order (chief complaint-based) and second-order (pain, mechanism of injury)
Pediatric version: PaedsCTAS (accounts for age-adjusted vitals, pediatric-specific presentations)
Highest reliability among all systems (κ = 0.7-0.95)

Pros: Very reliable, reassessment built in, robust pediatric version, well-validated Cons: Complex, takes 5-10 minutes to complete properly; requires training

4. Australasian Triage Scale (ATS) 🇦🇺

Used in: Australia, New Zealand Basis: Clinical urgency - time to treatment Levels: 5

Level	Category	Color	Max Time to Treatment	Duration of Assessment
1	Immediately Life-Threatening	Red	Immediate	Continuous
2	Imminently Life-Threatening	Orange	10 minutes	Every 10 min
3	Potentially Life-Threatening	Yellow	30 minutes	Every 30 min
4	Potentially Serious	Green	60 minutes	Every 60 min
5	Less Urgent	Blue	120 minutes	Every 120 min

Unique features:

Specifies initial assessment time (not just time to physician)
Explicitly states duration of each assessment
Includes mental health and social triage criteria

Pros: Time-based, clear, established nationally Cons: Moderate reliability (κ = 0.3-0.6); less resource-oriented

5. South African Triage Scale (SATS) 🇿🇦

Used in: South Africa, sub-Saharan Africa, resource-limited settings Basis: Triage Early Warning Score (TEWS) + presenting complaint discriminators Levels: 5

Level	Category	Color	Action
1	Emergency	Red	Immediate
2	Very Urgent	Orange	Within 10 min
3	Urgent	Yellow	Within 1 hour
4	Routine	Green	Within 4 hours
5	Not Urgent	Blue	Within 8 hours

TEWS scoring: Walking ability + respiratory rate + oxygen saturation + temperature + heart rate + systolic BP + AVPU

Unique: Designed for resource-limited settings; incorporates mobility assessment as a key first step

HEAD-TO-HEAD COMPARISON TABLE

Feature	ESI	MTS	CTAS	ATS	SATS
Origin	USA	UK	Canada	Australia	South Africa
Basis	Acuity + resources	Symptom flowcharts	Complaint + modifiers	Clinical urgency	TEWS + complaint
Levels	5	5	5	5	5
Time to complete	1-2 min	3-5 min	5-10 min	2-3 min	2-3 min
Mandatory reassessment	No	No	Yes	No	No
Pediatric version	Yes (ESI-Peds)	Yes (PaedsMTS)	Yes (PaedsCTAS)	Yes	Yes
Reliability (κ)	0.7-0.9	0.3-0.6	0.7-0.95	0.3-0.6	0.7
Best for	US EDs, resource prediction	European EDs, symptom-driven	High-reliability, training	Australian setting	Low-resource settings
Weakness	Resources subjective	Slow, poor for elderly/atypical	Complex, time-consuming	Moderate reliability	Limited international validation

No single triage system has proven clearly superior to the others - selection depends on setting, training, and local validation.

PART 2: MASS CASUALTY INCIDENT (MCI) TRIAGE SYSTEMS

Goal shifts from individual care to utilitarian: greatest good for greatest number. MCI defined as ≥5 patients overwhelming local resources.

Universal MCI Triage Color Categories

Color	Category	Meaning
🔴 Red	Immediate	Life-threatening; needs treatment NOW to survive
🟡 Yellow	Delayed	Serious but stable; can wait
🟢 Green	Minimal/Minor	"Walking wounded"; minor injuries
⚫ Black	Expectant/Dead	Injuries incompatible with survival given resources; or no signs of life
⚫ Gray	Expectant (SALT only)	Expected to die despite maximal intervention

1. START (Simple Triage And Rapid Treatment) 🇺🇸

Used: Prehospital/field triage, adults Speed: 30-60 seconds per patient Assessment: RPM - Respirations, Perfusion, Mental status

Algorithm:

Can the patient WALK?
    YES → GREEN (minimal/walking wounded)
    NO ↓
Is patient BREATHING?
    NO → Open airway → still not breathing? → BLACK (deceased)
         Breathing after opening? → RED (immediate)
    YES ↓
Respiratory rate?
    >30/min → RED (immediate)
    <10/min → RED (immediate)
    10-29/min ↓
Perfusion: Radial pulse or capillary refill >2 sec?
    No pulse / CRT >2 sec → RED (immediate) + hemorrhage control
    Pulse present / CRT ≤2 sec ↓
Mental status: Can follow simple commands?
    NO → RED (immediate)
    YES → YELLOW (delayed)

Key rule: During START, only two interventions allowed:

Open airway (head-tilt/chin-lift)
Direct pressure on obvious external hemorrhage

Pros: Fast, simple, validated in real MCI (2002 Placentia Linda train crash - 100% sensitivity for RED category) Cons: Requires capillary refill or respiratory rate (may be inaccurate in field); some overtriage

2. SALT (Sort, Assess, Lifesaving interventions, Treatment/Transport) 🇺🇸

Used: US national standard (CDC-recommended), prehospital + hospital Developed: 2011 by multidisciplinary consensus (Model Uniform Core Criteria)

Two-phase approach:

Phase 1 - SORT (global):

"If you can hear me and can walk, move to [safe area]" → GREEN
Assess remaining in priority: Still > Waving > Those who walked but couldn't relocate

Phase 2 - ASSESS (individual, one-by-one):

Assessment	Finding	Category
No signs of life	No breathing, no pulse	BLACK (dead)
Signs of life present	→ Perform brief lifesaving interventions if possible (control hemorrhage, open airway, give antidote)	↓
After interventions: Likely to survive?	Cannot follow commands + no peripheral pulse + poor breathing	GRAY (expectant)
Obeys commands OR has peripheral pulse OR normal breathing	→	RED (immediate)
Significant injury, not immediate	Can wait	YELLOW (delayed)
Minor / no injury	Ambulatory	GREEN (minimal)

Key difference from START: SALT adds GRAY category (expectant - will likely die) separate from BLACK (already dead) - eliminates ambiguity about dying but not yet dead patients

Pros: More precise categorization, all-hazards approach (trauma/medical/chemical/radiological), reduces undertriage by 9% vs START Cons: Slightly more complex; less studied in real disasters than START

Rosen's Emergency Medicine recommends START until more evidence on SALT accumulates.

3. JumpSTART (Pediatric MCI Triage)

Used: Children in MCI settings Modification of START with pediatric-specific criteria:

Step	START (Adults)	JumpSTART (Children)
Apneic patient	→ BLACK	→ Attempt 5 rescue breaths first → if still apneic → BLACK
Resp rate normal	10-29/min	15-45/min
Mental status	Follow commands	AVPU scale (Alert, Voice, Pain, Unresponsive)

4. CareFlight Triage

Used: Australia, some prehospital systems Steps: Walk → Obeys commands → Pulse → Respiratory effort

Performed best overall across all ages in multi-tool evaluation
Simpler than JumpSTART for pediatric victims

5. RAMP (Rapid Assessment of Mentation and Pulse)

Used: Emerging system, military and tactical medicine Basis: Mental status + pulse only

Faster than START (assesses only 2 parameters)
Results largely similar to START in final categorization
Suitable when time is extremely limited

PART 3: SPECIAL SITUATIONS IN TRIAGE

CBRN / Hazmat Triage

Decontamination BEFORE standard triage
Antidote administration (e.g., atropine for organophosphate) is a lifesaving intervention during SALT
PPE for triage personnel mandatory

Pediatric Considerations (Routine ED)

All major ED systems have pediatric versions (ESI, CTAS, MTS, ATS)
No single pediatric ED triage system proven superior
Pediatric Triage Tape (PTT): Length-based criteria for infants/toddlers in MCI settings

Geriatric Triage

Both ESI and MTS show limited sensitivity in elderly patients with atypical presentations (PLOS ONE, 2025)
ESI performs better than MTS for discriminating urgency in older adults
Current consensus: triage systems need revision to account for age-related vulnerability and non-specific presentations

QUICK REFERENCE SUMMARY

ROUTINE ED TRIAGE (most to least reliable):
CTAS > ESI > MTS > ATS > SATS

MCI/DISASTER TRIAGE:
Adults: START (most validated) or SALT (US national standard)
Children: JumpSTART (pediatric modification of START)

KEY PRINCIPLE DIFFERENCES:
ED triage   = save the sickest INDIVIDUAL
MCI triage  = save the MOST people with available resources

Different triage system for emergency physician

It looks like this is the same question you just asked — I provided a full detailed answer covering all major triage systems just a few minutes ago.

Here's a quick recap of what was covered:

Part 1 - Routine ED Triage Systems (5-level):

ESI (USA) - acuity + resource utilization
MTS / Manchester (UK/Europe) - symptom flowcharts
CTAS (Canada) - most reliable, mandatory reassessment intervals
ATS (Australia) - time-based, nationally mandated
SATS (South Africa) - TEWS scoring, resource-limited settings

Part 2 - Mass Casualty / MCI Triage:

START - adult field triage (RPM assessment, 30-60 sec/patient)
SALT - US national standard (Sort→Assess→Lifesaving interventions), adds Gray category
JumpSTART - pediatric modification of START
CareFlight - best overall performance in pediatric evaluations
RAMP - rapid 2-parameter assessment (mentation + pulse)

Part 3 - Special considerations:

CBRN/Hazmat triage
Geriatric triage limitations
Pediatric ED triage systems

Scroll up to see the full detailed note with algorithms, color categories, time targets, comparison tables, and decision flowcharts. Let me know if you'd like me to expand on any specific system or add anything!

Generate a pocket guide PDF for ESI vs CTAS decision-making

Reading File

Running Command

ls -la /home/daytona/workspace/ 2>/dev/null || echo "workspace does not exist"

Running Command

mkdir -p /home/daytona/workspace/triage-guide && python3 -c "import reportlab; print('reportlab ok')"

Writing File

~/triage-guide/generate_pocket_guide.py

from reportlab.lib.pagesizes import A4
from reportlab.lib import colors
from reportlab.lib.units import mm, cm
from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle
from reportlab.lib.enums import TA_CENTER, TA_LEFT, TA_RIGHT
from reportlab.platypus import (
    SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle,
    HRFlowable, KeepTogether
)
from reportlab.platypus.flowables import HRFlowable
from reportlab.lib.colors import HexColor

# ── Colour palette ──────────────────────────────────────────────────────────
NAVY      = HexColor('#0D1B4B')
TEAL      = HexColor('#0077A8')
ORANGE    = HexColor('#E05A00')
LIGHT_BG  = HexColor('#F0F4FA')
WHITE     = colors.white

# Triage level colours
RED       = HexColor('#C62828')
ORANGE_T  = HexColor('#E65100')
YELLOW_T  = HexColor('#F9A825')
GREEN_T   = HexColor('#2E7D32')
BLUE_T    = HexColor('#1565C0')

L_RED     = HexColor('#FFCDD2')
L_ORANGE  = HexColor('#FFE0B2')
L_YELLOW  = HexColor('#FFF9C4')
L_GREEN   = HexColor('#C8E6C9')
L_BLUE    = HexColor('#BBDEFB')

# ── Document setup ──────────────────────────────────────────────────────────
OUTPUT = '/home/daytona/workspace/triage-guide/ESI_vs_CTAS_Pocket_Guide.pdf'
doc = SimpleDocTemplate(
    OUTPUT,
    pagesize=A4,
    leftMargin=14*mm, rightMargin=14*mm,
    topMargin=14*mm,  bottomMargin=14*mm,
    title='ESI vs CTAS Pocket Guide',
    author='Emergency Medicine Reference'
)

# ── Styles ───────────────────────────────────────────────────────────────────
styles = getSampleStyleSheet()

def S(name, **kw):
    return ParagraphStyle(name, **kw)

title_style = S('Title2',
    fontName='Helvetica-Bold', fontSize=18,
    textColor=WHITE, alignment=TA_CENTER, leading=22)

subtitle_style = S('Sub',
    fontName='Helvetica', fontSize=9,
    textColor=HexColor('#BBDEFB'), alignment=TA_CENTER, leading=12)

section_style = S('Section',
    fontName='Helvetica-Bold', fontSize=11,
    textColor=WHITE, alignment=TA_CENTER, leading=14)

body_style = S('Body2',
    fontName='Helvetica', fontSize=8.5,
    textColor=HexColor('#1A1A2E'), leading=12)

small_style = S('Small',
    fontName='Helvetica', fontSize=7.5,
    textColor=HexColor('#333355'), leading=10)

bold_small = S('BoldSmall',
    fontName='Helvetica-Bold', fontSize=8,
    textColor=HexColor('#1A1A2E'), leading=11)

note_style = S('Note',
    fontName='Helvetica-Oblique', fontSize=7.5,
    textColor=HexColor('#444466'), leading=10)

cell_style = S('Cell',
    fontName='Helvetica', fontSize=8,
    textColor=HexColor('#1A1A2E'), leading=11, alignment=TA_LEFT)

cell_bold = S('CellBold',
    fontName='Helvetica-Bold', fontSize=8.5,
    textColor=HexColor('#1A1A2E'), leading=11, alignment=TA_LEFT)

hdr_style = S('Hdr',
    fontName='Helvetica-Bold', fontSize=9,
    textColor=WHITE, alignment=TA_CENTER, leading=12)

# ── Helper to build a coloured header banner ─────────────────────────────────
def banner(text, bg=NAVY, text_style=None):
    ts = text_style or section_style
    tbl = Table([[Paragraph(text, ts)]], colWidths=[182*mm])
    tbl.setStyle(TableStyle([
        ('BACKGROUND', (0,0), (-1,-1), bg),
        ('TOPPADDING',    (0,0), (-1,-1), 5),
        ('BOTTOMPADDING', (0,0), (-1,-1), 5),
        ('LEFTPADDING',   (0,0), (-1,-1), 8),
        ('RIGHTPADDING',  (0,0), (-1,-1), 8),
        ('ROUNDEDCORNERS', [4,4,4,4]),
    ]))
    return tbl

# ── Title block ───────────────────────────────────────────────────────────────
title_tbl = Table(
    [[Paragraph('ESI vs CTAS', title_style)],
     [Paragraph('Emergency Triage Pocket Guide  |  For Emergency Physicians & Nurses', subtitle_style)]],
    colWidths=[182*mm]
)
title_tbl.setStyle(TableStyle([
    ('BACKGROUND', (0,0), (-1,-1), NAVY),
    ('TOPPADDING',    (0,0), (-1,-1), 8),
    ('BOTTOMPADDING', (0,0), (-1,-1), 8),
    ('LEFTPADDING',   (0,0), (-1,-1), 10),
    ('RIGHTPADDING',  (0,0), (-1,-1), 10),
]))

# ── ESI decision algorithm table ──────────────────────────────────────────────
esi_algo = [
    [Paragraph('<b>Step</b>', hdr_style),
     Paragraph('<b>Question</b>', hdr_style),
     Paragraph('<b>Answer</b>', hdr_style),
     Paragraph('<b>Level</b>', hdr_style)],
    [Paragraph('1', cell_bold),
     Paragraph('Immediate life-saving intervention needed?', cell_style),
     Paragraph('YES', cell_style),
     Paragraph('Level 1 🔴', cell_bold)],
    [Paragraph('2', cell_bold),
     Paragraph('High-risk / confused / severe distress / dangerous vitals?', cell_style),
     Paragraph('YES', cell_style),
     Paragraph('Level 2 🟠', cell_bold)],
    [Paragraph('3', cell_bold),
     Paragraph('How many RESOURCES needed?', cell_style),
     Paragraph('≥ 2 resources\n1 resource\n0 resources', cell_style),
     Paragraph('Level 3 🟡\nLevel 4 🟢\nLevel 5 🔵', cell_bold)],
    [Paragraph('3a', cell_bold),
     Paragraph('If Level 3: Are vitals dangerous?', cell_style),
     Paragraph('YES → upgrade', cell_style),
     Paragraph('Level 2 🟠', cell_bold)],
]

esi_algo_tbl = Table(esi_algo, colWidths=[13*mm, 72*mm, 45*mm, 30*mm])
esi_algo_tbl.setStyle(TableStyle([
    ('BACKGROUND',    (0,0), (-1,0), NAVY),
    ('BACKGROUND',    (0,1), (-1,1), L_RED),
    ('BACKGROUND',    (0,2), (-1,2), L_ORANGE),
    ('BACKGROUND',    (0,3), (-1,3), L_YELLOW),
    ('BACKGROUND',    (0,4), (-1,4), L_ORANGE),
    ('FONTNAME',      (0,0), (-1,0), 'Helvetica-Bold'),
    ('FONTSIZE',      (0,0), (-1,-1), 8),
    ('GRID',          (0,0), (-1,-1), 0.4, HexColor('#AABBCC')),
    ('VALIGN',        (0,0), (-1,-1), 'MIDDLE'),
    ('TOPPADDING',    (0,0), (-1,-1), 4),
    ('BOTTOMPADDING', (0,0), (-1,-1), 4),
    ('LEFTPADDING',   (0,0), (-1,-1), 5),
    ('RIGHTPADDING',  (0,0), (-1,-1), 5),
]))

# ── ESI Vital sign danger zone table ─────────────────────────────────────────
vitals_data = [
    [Paragraph('<b>Parameter</b>', hdr_style),
     Paragraph('<b>Age <3 mo</b>', hdr_style),
     Paragraph('<b>3 mo–3 yr</b>', hdr_style),
     Paragraph('<b>3–8 yr</b>', hdr_style),
     Paragraph('<b>>8 yr / Adult</b>', hdr_style)],
    ['HR > (bpm)', '>180', '>160', '>140', '>100'],
    ['HR < (bpm)', '<50',  '<50',  '<50',  '<50'],
    ['RR > (bpm)', '>50',  '>40',  '>30',  '>20'],
    ['SpO₂ <',     '<92%', '<92%', '<92%', '<92%'],
    ['Temp °C >',  '>38',  '>38.5','—',    '>38.5'],
]
vitals_tbl = Table(vitals_data, colWidths=[28*mm, 28*mm, 28*mm, 28*mm, 40*mm])
vitals_tbl.setStyle(TableStyle([
    ('BACKGROUND',    (0,0), (-1,0), TEAL),
    ('BACKGROUND',    (0,1), (-1,1), HexColor('#F8F8FF')),
    ('BACKGROUND',    (0,2), (-1,2), HexColor('#F0F0FF')),
    ('BACKGROUND',    (0,3), (-1,3), HexColor('#F8F8FF')),
    ('BACKGROUND',    (0,4), (-1,4), HexColor('#F0F0FF')),
    ('BACKGROUND',    (0,5), (-1,5), HexColor('#F8F8FF')),
    ('FONTNAME',      (0,0), (-1,0), 'Helvetica-Bold'),
    ('FONTNAME',      (0,1), (0,-1), 'Helvetica-Bold'),
    ('FONTSIZE',      (0,0), (-1,-1), 7.5),
    ('ALIGN',         (0,0), (-1,-1), 'CENTER'),
    ('GRID',          (0,0), (-1,-1), 0.4, HexColor('#AABBCC')),
    ('VALIGN',        (0,0), (-1,-1), 'MIDDLE'),
    ('TOPPADDING',    (0,0), (-1,-1), 3),
    ('BOTTOMPADDING', (0,0), (-1,-1), 3),
]))

# ── CTAS decision table ───────────────────────────────────────────────────────
ctas_data = [
    [Paragraph('<b>Level</b>', hdr_style),
     Paragraph('<b>Category</b>', hdr_style),
     Paragraph('<b>Colour</b>', hdr_style),
     Paragraph('<b>Time to MD</b>', hdr_style),
     Paragraph('<b>Reassess</b>', hdr_style),
     Paragraph('<b>Examples</b>', hdr_style)],
    ['1', 'Resuscitation',  '🔴 Red',    'Immediate',  'Continuous',
     'Cardiac arrest, apnoea, RSI needed'],
    ['2', 'Emergent',       '🟠 Orange', '≤15 min',    'q15 min',
     'STEMI, stroke, sepsis, major trauma'],
    ['3', 'Urgent',         '🟡 Yellow', '≤30 min',    'q30 min',
     'Moderate pain, stable GI bleed, seizure (postictal)'],
    ['4', 'Less Urgent',    '🟢 Green',  '≤60 min',    'q60 min',
     'Minor injury, sore throat, UTI symptoms'],
    ['5', 'Non-Urgent',     '🔵 Blue',   '≤120 min',   'q120 min',
     'Prescription refill, rash, well-child concern'],
]
ctas_tbl = Table(ctas_data, colWidths=[10*mm, 28*mm, 18*mm, 22*mm, 20*mm, 64*mm])
ctas_tbl.setStyle(TableStyle([
    ('BACKGROUND',    (0,0), (-1,0), NAVY),
    ('BACKGROUND',    (0,1), (-1,1), L_RED),
    ('BACKGROUND',    (0,2), (-1,2), L_ORANGE),
    ('BACKGROUND',    (0,3), (-1,3), L_YELLOW),
    ('BACKGROUND',    (0,4), (-1,4), L_GREEN),
    ('BACKGROUND',    (0,5), (-1,5), L_BLUE),
    ('FONTNAME',      (0,0), (-1,0), 'Helvetica-Bold'),
    ('FONTNAME',      (0,1), (0,-1), 'Helvetica-Bold'),
    ('FONTSIZE',      (0,0), (-1,-1), 7.5),
    ('ALIGN',         (1,0), (4,-1), 'CENTER'),
    ('GRID',          (0,0), (-1,-1), 0.4, HexColor('#AABBCC')),
    ('VALIGN',        (0,0), (-1,-1), 'MIDDLE'),
    ('TOPPADDING',    (0,0), (-1,-1), 4),
    ('BOTTOMPADDING', (0,0), (-1,-1), 4),
    ('LEFTPADDING',   (0,0), (-1,-1), 4),
    ('RIGHTPADDING',  (0,0), (-1,-1), 4),
]))

# ── ESI Level detailed table ──────────────────────────────────────────────────
esi_levels = [
    [Paragraph('<b>Level</b>', hdr_style),
     Paragraph('<b>Category</b>', hdr_style),
     Paragraph('<b>Basis for Decision</b>', hdr_style),
     Paragraph('<b>Wait Time</b>', hdr_style),
     Paragraph('<b>Clinical Examples</b>', hdr_style)],
    ['1', 'Resuscitation',
     'Immediate life-saving intervention required NOW',
     'Immediate',
     'Intubation, cardioversion, CPR, massive haemorrhage'],
    ['2', 'Emergent',
     'High-risk; confused/lethargic; severe pain/distress; danger vitals',
     '<15 min',
     'STEMI, anaphylaxis, active seizure, severe dyspnoea, suicidal'],
    ['3', 'Urgent',
     '≥2 resources needed; vitals normal or mildly abnormal',
     '<30 min',
     'Abdominal pain (labs + CT), moderate asthma (neb + CXR)'],
    ['4', 'Less Urgent',
     'Only 1 resource needed; no distress',
     '<60 min',
     'Ankle sprain (X-ray only), simple laceration (repair only)'],
    ['5', 'Non-Urgent',
     '0 resources; history + exam only',
     '<120 min',
     'Prescription refill, cold symptoms, well-controlled chronic disease'],
]
esi_levels_tbl = Table(esi_levels, colWidths=[10*mm, 25*mm, 55*mm, 20*mm, 60*mm])
esi_levels_tbl.setStyle(TableStyle([
    ('BACKGROUND',    (0,0), (-1,0), NAVY),
    ('BACKGROUND',    (0,1), (-1,1), L_RED),
    ('BACKGROUND',    (0,2), (-1,2), L_ORANGE),
    ('BACKGROUND',    (0,3), (-1,3), L_YELLOW),
    ('BACKGROUND',    (0,4), (-1,4), L_GREEN),
    ('BACKGROUND',    (0,5), (-1,5), L_BLUE),
    ('FONTNAME',      (0,0), (-1,0), 'Helvetica-Bold'),
    ('FONTNAME',      (0,1), (0,-1), 'Helvetica-Bold'),
    ('FONTSIZE',      (0,0), (-1,-1), 7.5),
    ('ALIGN',         (1,0), (3,-1), 'CENTER'),
    ('GRID',          (0,0), (-1,-1), 0.4, HexColor('#AABBCC')),
    ('VALIGN',        (0,0), (-1,-1), 'MIDDLE'),
    ('TOPPADDING',    (0,0), (-1,-1), 4),
    ('BOTTOMPADDING', (0,0), (-1,-1), 4),
    ('LEFTPADDING',   (0,0), (-1,-1), 4),
    ('RIGHTPADDING',  (0,0), (-1,-1), 4),
]))

# ── Side-by-side comparison table ────────────────────────────────────────────
compare_data = [
    [Paragraph('<b>Feature</b>', hdr_style),
     Paragraph('<b>ESI</b>', hdr_style),
     Paragraph('<b>CTAS</b>', hdr_style)],
    ['Origin / Country', 'USA (AHRQ)', 'Canada (CAEP)'],
    ['Decision Basis', 'Acuity + Expected Resources', 'Chief Complaint + Modifiers + Vitals'],
    ['Time to Complete', '1–2 minutes', '5–10 minutes'],
    ['Mandatory Reassessment', '✗  (only when needed)', '✓  At fixed intervals per level'],
    ['Paediatric Version', 'ESI Paeds (same algorithm)', 'PaedsCTAS (age-adjusted criteria)'],
    ['Reliability (κ)', '0.70–0.90', '0.70–0.95 (highest of all systems)'],
    ['Unique Strength', 'Resource prediction; fast', 'Built-in safety net (reassessment)'],
    ['Main Weakness', 'Resources subjective; variable across countries', 'Complex; requires training; time-intensive'],
    ['Best Setting', 'High-volume US EDs; resource allocation focus', 'Any ED; especially when structured monitoring needed'],
    ['Pain Score Used?', '✓  (for Level 2 consideration)', '✓  (first-order modifier)'],
    ['Vital Sign Threshold', 'Triggers Level 2 upgrade from Level 3', 'Incorporated as modifiers for level adjustment'],
    ['Non-disabling mild symptoms', 'Level 4 or 5', 'Level 4 or 5'],
]
compare_tbl = Table(compare_data, colWidths=[48*mm, 67*mm, 67*mm])
compare_tbl.setStyle(TableStyle([
    ('BACKGROUND',    (0,0), (-1,0), NAVY),
    ('BACKGROUND',    (0,1), (-1,1), LIGHT_BG),
    ('BACKGROUND',    (0,2), (-1,2), WHITE),
    ('BACKGROUND',    (0,3), (-1,3), LIGHT_BG),
    ('BACKGROUND',    (0,4), (-1,4), WHITE),
    ('BACKGROUND',    (0,5), (-1,5), LIGHT_BG),
    ('BACKGROUND',    (0,6), (-1,6), WHITE),
    ('BACKGROUND',    (0,7), (-1,7), LIGHT_BG),
    ('BACKGROUND',    (0,8), (-1,8), WHITE),
    ('BACKGROUND',    (0,9), (-1,9), LIGHT_BG),
    ('BACKGROUND',    (0,10),(-1,10),WHITE),
    ('BACKGROUND',    (0,11),(-1,11),LIGHT_BG),
    ('BACKGROUND',    (0,12),(-1,12),WHITE),
    ('FONTNAME',      (0,0), (-1,0), 'Helvetica-Bold'),
    ('FONTNAME',      (0,1), (0,-1), 'Helvetica-Bold'),
    ('FONTSIZE',      (0,0), (-1,-1), 8),
    ('GRID',          (0,0), (-1,-1), 0.4, HexColor('#AABBCC')),
    ('VALIGN',        (0,0), (-1,-1), 'MIDDLE'),
    ('TOPPADDING',    (0,0), (-1,-1), 4),
    ('BOTTOMPADDING', (0,0), (-1,-1), 4),
    ('LEFTPADDING',   (0,0), (-1,-1), 5),
    ('RIGHTPADDING',  (0,0), (-1,-1), 5),
]))

# ── CTAS Modifiers box ────────────────────────────────────────────────────────
ctas_mod_data = [
    [Paragraph('<b>CTAS Modifiers (Adjust Level Up/Down)</b>', hdr_style)],
    [Paragraph(
        '<b>First-Order (Chief-Complaint Based):</b> Mechanism of injury, acuity of onset, '
        'severity of pain/discomfort (NRS ≥8 → consider upgrading by 1 level)<br/><br/>'
        '<b>Second-Order (Adding Context):</b> Age extremes (&lt;2 yr or &gt;70 yr), '
        'immunocompromised state, mechanism, co-morbidities, patient distress<br/><br/>'
        '<b>Key Rule:</b> Reassessment at mandated intervals is REQUIRED. '
        'If patient deteriorates → upgrade immediately. Document reassessment time.',
        small_style)],
]
ctas_mod_tbl = Table(ctas_mod_data, colWidths=[182*mm])
ctas_mod_tbl.setStyle(TableStyle([
    ('BACKGROUND',    (0,0), (-1,0), TEAL),
    ('BACKGROUND',    (0,1), (-1,1), HexColor('#E8F4FD')),
    ('GRID',          (0,0), (-1,-1), 0.4, HexColor('#AABBCC')),
    ('TOPPADDING',    (0,0), (-1,-1), 5),
    ('BOTTOMPADDING', (0,0), (-1,-1), 5),
    ('LEFTPADDING',   (0,0), (-1,-1), 7),
    ('RIGHTPADDING',  (0,0), (-1,-1), 7),
]))

# ── Clinical tips box ─────────────────────────────────────────────────────────
tips_data = [
    [Paragraph('<b>Clinical Decision Tips  — ESI</b>', hdr_style),
     Paragraph('<b>Clinical Decision Tips  — CTAS</b>', hdr_style)],
    [Paragraph(
        '• <b>Disabling deficit</b> at any NIHSS → Level 2 (do not rely solely on NIHSS)<br/>'
        '• Severe pain (NRS ≥8) alone → consider Level 2<br/>'
        '• Normal vitals do NOT rule out Level 2 (high-risk history trumps)<br/>'
        '• "Resources" = distinct services ordered (one CBC = 1, CBC+BMP = still 1 lab draw)<br/>'
        '• CT scan = 1 resource; CT + labs = 2 resources = Level 3 minimum<br/>'
        '• Confused/altered → automatically Level 2<br/>'
        '• Child with fever: apply paediatric danger vital thresholds',
        small_style),
     Paragraph(
        '• Use <b>first positive discriminator</b> — do not skip down flowchart<br/>'
        '• Age &lt;2 or &gt;70 → consider upgrading one level<br/>'
        '• Missed reassessment = patient safety risk — document every interval<br/>'
        '• Pain ≥8/10 → upgrade by 1 level as first-order modifier<br/>'
        '• Immunocompromised patients (HIV, chemo, transplant) → upgrade<br/>'
        '• If in doubt between two levels → always assign the <b>higher acuity</b> level<br/>'
        '• Sepsis criteria present → Level 2 at minimum',
        small_style)],
]
tips_tbl = Table(tips_data, colWidths=[91*mm, 91*mm])
tips_tbl.setStyle(TableStyle([
    ('BACKGROUND',    (0,0), (0,0), ORANGE),
    ('BACKGROUND',    (1,0), (1,0), TEAL),
    ('BACKGROUND',    (0,1), (0,1), HexColor('#FFF3E0')),
    ('BACKGROUND',    (1,1), (1,1), HexColor('#E0F2FF')),
    ('GRID',          (0,0), (-1,-1), 0.4, HexColor('#AABBCC')),
    ('VALIGN',        (0,0), (-1,-1), 'TOP'),
    ('TOPPADDING',    (0,0), (-1,-1), 5),
    ('BOTTOMPADDING', (0,0), (-1,-1), 5),
    ('LEFTPADDING',   (0,0), (-1,-1), 6),
    ('RIGHTPADDING',  (0,0), (-1,-1), 6),
]))

# ── Level-to-Level concordance table ─────────────────────────────────────────
concordance_data = [
    [Paragraph('<b>ESI Level</b>', hdr_style),
     Paragraph('<b>Approximate CTAS Equivalent</b>', hdr_style),
     Paragraph('<b>Notes on Differences</b>', hdr_style)],
    ['Level 1 🔴', 'Level 1 🔴', 'Identical — immediate life threat'],
    ['Level 2 🟠', 'Level 2 🟠', 'ESI 2 is slightly broader (includes any high-risk without immediate need)'],
    ['Level 3 🟡', 'Level 2–3 🟠🟡', 'CTAS uses modifiers; ESI 3 with danger vitals → CTAS 2'],
    ['Level 4 🟢', 'Level 4 🟢', 'Very similar — one resource / less urgent'],
    ['Level 5 🔵', 'Level 5 🔵', 'Identical — no resources / non-urgent'],
]
concordance_tbl = Table(concordance_data, colWidths=[35*mm, 55*mm, 92*mm])
concordance_tbl.setStyle(TableStyle([
    ('BACKGROUND',    (0,0), (-1,0), NAVY),
    ('BACKGROUND',    (0,1), (-1,1), L_RED),
    ('BACKGROUND',    (0,2), (-1,2), L_ORANGE),
    ('BACKGROUND',    (0,3), (-1,3), L_YELLOW),
    ('BACKGROUND',    (0,4), (-1,4), L_GREEN),
    ('BACKGROUND',    (0,5), (-1,5), L_BLUE),
    ('FONTNAME',      (0,0), (-1,0), 'Helvetica-Bold'),
    ('FONTNAME',      (0,1), (0,-1), 'Helvetica-Bold'),
    ('FONTSIZE',      (0,0), (-1,-1), 8),
    ('GRID',          (0,0), (-1,-1), 0.4, HexColor('#AABBCC')),
    ('VALIGN',        (0,0), (-1,-1), 'MIDDLE'),
    ('TOPPADDING',    (0,0), (-1,-1), 4),
    ('BOTTOMPADDING', (0,0), (-1,-1), 4),
    ('LEFTPADDING',   (0,0), (-1,-1), 5),
    ('RIGHTPADDING',  (0,0), (-1,-1), 5),
]))

# ── Footer ────────────────────────────────────────────────────────────────────
footer_data = [[
    Paragraph(
        'ESI: Emergency Severity Index (AHRQ, USA)  |  CTAS: Canadian Triage and Acuity Scale (CAEP)  |  '
        'Pocket guide for clinical reference only — always apply clinical judgement  |  '
        'Compiled June 2026',
        note_style)
]]
footer_tbl = Table(footer_data, colWidths=[182*mm])
footer_tbl.setStyle(TableStyle([
    ('BACKGROUND', (0,0), (-1,-1), LIGHT_BG),
    ('TOPPADDING',    (0,0), (-1,-1), 4),
    ('BOTTOMPADDING', (0,0), (-1,-1), 4),
    ('LEFTPADDING',   (0,0), (-1,-1), 6),
    ('RIGHTPADDING',  (0,0), (-1,-1), 6),
    ('BOX', (0,0), (-1,-1), 0.5, HexColor('#AABBCC')),
]))

# ── Assemble story ────────────────────────────────────────────────────────────
story = [
    title_tbl,
    Spacer(1, 4*mm),

    # Page 1: ESI
    KeepTogether([
        banner('1.  ESI — Emergency Severity Index (USA)', ORANGE),
        Spacer(1, 2*mm),
        banner('1a  ESI Decision Algorithm', TEAL),
        Spacer(1, 1*mm),
        esi_algo_tbl,
        Spacer(1, 2*mm),
    ]),

    KeepTogether([
        banner('1b  ESI — Full Level Details', TEAL),
        Spacer(1, 1*mm),
        esi_levels_tbl,
        Spacer(1, 2*mm),
    ]),

    KeepTogether([
        banner('1c  ESI — Vital Sign Danger Thresholds (trigger Level 2 upgrade)', TEAL),
        Spacer(1, 1*mm),
        vitals_tbl,
        Spacer(1, 3*mm),
    ]),

    # Page 2: CTAS
    KeepTogether([
        banner('2.  CTAS — Canadian Triage and Acuity Scale', ORANGE),
        Spacer(1, 2*mm),
        banner('2a  CTAS Level Reference', TEAL),
        Spacer(1, 1*mm),
        ctas_tbl,
        Spacer(1, 2*mm),
    ]),

    KeepTogether([
        banner('2b  CTAS — Modifiers & Reassessment Rules', TEAL),
        Spacer(1, 1*mm),
        ctas_mod_tbl,
        Spacer(1, 3*mm),
    ]),

    # Comparison section
    KeepTogether([
        banner('3.  ESI vs CTAS — Head-to-Head Comparison', NAVY),
        Spacer(1, 1*mm),
        compare_tbl,
        Spacer(1, 3*mm),
    ]),

    KeepTogether([
        banner('4.  Level Concordance  (ESI ↔ CTAS)', NAVY),
        Spacer(1, 1*mm),
        concordance_tbl,
        Spacer(1, 3*mm),
    ]),

    KeepTogether([
        banner('5.  Clinical Tips at the Triage Desk', NAVY),
        Spacer(1, 1*mm),
        tips_tbl,
        Spacer(1, 3*mm),
    ]),

    footer_tbl,
]

doc.build(story)
print(f"PDF created: {OUTPUT}")

Running Command

python3 /home/daytona/workspace/triage-guide/generate_pocket_guide.py

Running Command

ls -lh /home/daytona/workspace/triage-guide/

Your pocket guide is ready:

ESI vs CTAS Pocket Guide
PDF Document · PDF

What's inside the guide:

Section	Content
1. ESI Decision Algorithm	3-step flowchart (life threat → high risk → resources) with colour coding
2. ESI Full Level Details	All 5 levels with criteria, wait times, and clinical examples
3. ESI Vital Sign Thresholds	Age-stratified danger vitals that trigger Level 2 upgrade
4. CTAS Level Reference	All 5 levels with time-to-physician, mandatory reassessment intervals, examples
5. CTAS Modifiers	First-order and second-order modifier rules + reassessment documentation note
6. Head-to-Head Comparison	12-row feature comparison (origin, basis, reliability, strengths, weaknesses)
7. Level Concordance	ESI ↔ CTAS equivalent mapping with notes on key differences
8. Clinical Tips at the Desk	7 tips each for ESI and CTAS, side by side

Formatted as a colour-coded A4 document with triage-standard red/orange/yellow/green/blue level colours throughout - suitable for printing and laminating for the triage desk.

This is a shared conversation. Sign in to Orris to start your own chat.